Immunosuppressant Medications and Mortality in Inflammatory Bowel Disease

@article{Lewis2008ImmunosuppressantMA,
  title={Immunosuppressant Medications and Mortality in Inflammatory Bowel Disease},
  author={J. Lewis and J. Gelfand and A. Troxel and K. Forde and C. Newcomb and Hopiy Kim and D. Margolis and B. Strom},
  journal={The American Journal of Gastroenterology},
  year={2008},
  volume={103},
  pages={1428-1435}
}
  • J. Lewis, J. Gelfand, +5 authors B. Strom
  • Published 2008
  • Medicine
  • The American Journal of Gastroenterology
  • OBJECTIVE:This study examined whether treatment of Crohn's disease (CD) and ulcerative colitis (UC) with immunosuppressant medications was associated with an increased risk of death in the era prior to antitumor necrosis factor (TNF) therapies.DESIGN: This retrospective cohort study used data from the General Practice Research Database from 1987 to 1997. CD and UC patients were matched to controls on age, sex, and primary care practice. CD and UC patients were stratified according to whether… CONTINUE READING
    84 Citations
    Increased Risk of Pneumonia Among Patients With Inflammatory Bowel Disease
    • 94
    Dying to save your colon? Changing the way we look at ulcerative colitis
    Mortality Associated With Medical Therapy Versus Elective Colectomy in Ulcerative Colitis
    • 33

    References

    SHOWING 1-10 OF 32 REFERENCES
    Mortality in inflammatory bowel disease: a population-based cohort study.
    • 150
    Incidence and risk factors for herpes zoster among patients with inflammatory bowel disease.
    • Gauree Gupta, E. Lautenbach, J. Lewis
    • Medicine
    • Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
    • 2006
    • 142
    Serious infections and mortality in association with therapies for Crohn's disease: TREAT registry.
    • G. Lichtenstein, B. Feagan, +5 authors W. Sandborn
    • Medicine
    • Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
    • 2006
    • 821
    • Highly Influential
    Antibiotic use and the risk of flare of inflammatory bowel disease.
    • 40
    Seasonal variation in flares of inflammatory bowel disease.
    • 81
    The safety profile of infliximab in patients with Crohn's disease: the Mayo clinic experience in 500 patients.
    • 885